Adicet bio to participate in a fireside chat at the canaccord genuity 43rd annual growth conference

Redwood city, calif. & boston--(business wire)--adicet bio, inc. (nasdaq: acet), a clinical stage biotechnology company discovering and developing allogeneic gamma delta t cell therapies for cancer, today announced that chen schor, president and chief executive officer, will participate in a fireside chat at the canaccord genuity 43rd annual growth conference being held from august 7-10, 2023 in boston. details of the event are as follows: date: wednesday, august 9, 2023 time: 1:00 p.m. et the.
ACET Ratings Summary
ACET Quant Ranking